

American Journal of Hematology accepts Telo Genomics' study on TeloViewSMM, a prognostic test for smoldering multiple myeloma. The test showed 85% positive and...
You can purchase shares of TELO GENOMICS CORP by Telo Genomics Corp. (OTCQB:TDSGF) through any online brokerage.
There are no as such competitors for TELO GENOMICS CORP by Telo Genomics Corp..
There is no analysis for TELO GENOMICS CORP by Telo Genomics Corp. to provide a consensus price target.
The stock price for TELO GENOMICS CORP by Telo Genomics Corp. (OTCQB: TDSGF) is $0.0296 last updated November 10, 2026 at 9:30 AM EST.
There are no upcoming dividends for TELO GENOMICS CORP by Telo Genomics Corp..
TELO GENOMICS CORP by Telo Genomics Corp. does not have any upcoming earnings scheduled.
There is no upcoming split for TELO GENOMICS CORP by Telo Genomics Corp..
TELO GENOMICS CORP by Telo Genomics Corp. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.
Telo Genomics Corp is developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating...